Inscopix news and milestones

Revolutionizing Neural Circuit Imaging in Freely Behaving Animal Research SAN JOSE, Calif.-(BUSINESS WIRE)- Bruker Corporation (Nasdaq: BRKR) today announced the launch of the nV…

2024 was a year full of researchers finding innovative approaches to explore different processes and structures in the brain. Some of these studies focused on finding different n…

The SfN annual meeting continues to be an amazing opportunity for researchers around the world to come together to share and discuss their ideas driving innovative neuroscience r…

Alzheimer's disease is the leading neurological aging disorder impacting the lives of nearly 7 million Americans and 55 million individuals around the world. Alzheimer's is the m…

Those of us who work in the Neurosciences are familiar with the variety of brain-related disorders that plague our society, often citing them to justify funding and support for o…

Simultaneous observation of Sapap3-KO compulsive grooming (left) and central striatum neuron activity (right) using nVista miniature microscope. Data courtesy of Susanne E. Ahmar…

Parkinson's disease (PD) is a neurological disorder that affects 6 hundred thousand to more than 1 million people in the United States, or over 6 million worldwide, making it the…

From behavioral studies on learning and memory to sleep-wakefulness, 2023 was a year full of researchers uncovering interesting insights into the brain using Inscopix miniscopes.…

As a neuroscientist who leads a commercial organization, my mission and motivation come from seeing how our customers use Inscopix technology to address major questions in their…

Inscopix today announced a collaboration with Bruker Corporation for its new Multimodal Image Registration and Analysis platform. "We are very excited to announce the launch of t…

PALO ALTO, Calif. and NEW ORLEANS, Oct. 10, 2012/ PRNewswire/-- Inscopix, Inc. will announce the launch of nVista HD, an end-to-end solution for in vivo brain imaging in freely b…